Developing a Broad-Spectrum Ebola Treatment

Einstein Magazine profiles our work on the development of a broadly active human antibody therapeutic cocktail against Ebola virus and related agents in their feature entitled “Translating Discoveries Into Therapies.” This cocktail is being developed by our biotech partner Mapp Bio with support from the US Biomedical Advanced Research and Development Authority (BARDA).